does tirzepatide reduce visceral fat Metabolic disease is not just a “weight issue.” It changes the internal terrain of the body. When insulin resistance, fat, chronic inflammation, poor glucose control, fatty liver, low muscle mass, and Tirzepatide: A Breakthrough Approach to

Cell Death & Disease, 13 (1), Article 40

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday

Protein does more than just build muscle

Here, we show that SYGL-1 protein abundance disappears in a pattern closely mirroring loss of its mRNAs

Andrew Huberman Dr

Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry